Ptc Therapeutics, Inc. financial data

Symbol
PTCT on Nasdaq
Location
500 Warren Corporate Center Drive, Warren, NJ
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 300 % +59.4%
Quick Ratio 4.75 % -15.6%
Debt-to-equity -447 % -47.1%
Return On Assets 28.5 %
Operating Margin 40.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 79.4M shares +3.27%
Common Stock, Shares, Outstanding 79.4M shares +3.22%
Entity Public Float 1.73B USD -25.6%
Common Stock, Value, Issued 78K USD +2.63%
Weighted Average Number of Shares Outstanding, Basic 78.2M shares +1.86%
Weighted Average Number of Shares Outstanding, Diluted 78.2M shares +1.86%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.76B USD +96%
Research and Development Expense 508M USD -4.82%
Operating Income (Loss) 718M USD +13.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 666M USD +17.1%
Income Tax Expense (Benefit) 36.9M USD -146%
Net Income (Loss) Attributable to Parent 629M USD +34.6%
Earnings Per Share, Basic 8 USD/shares +35.7%
Earnings Per Share, Diluted 6 USD/shares +35.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.02B USD +55.4%
Marketable Securities, Current 972M USD +122%
Inventory, Net 34.1M USD +7.02%
Assets, Current 2.27B USD +67.4%
Property, Plant and Equipment, Net 57.2M USD -13.3%
Operating Lease, Right-of-Use Asset 56.2M USD -1.7%
Intangible Assets, Net (Excluding Goodwill) 144M USD -56.4%
Goodwill 82.3M USD 0%
Assets 2.63B USD +37.5%
Accounts Payable, Current 26.5M USD +9.17%
Employee-related Liabilities, Current 38.2M USD +4.18%
Contract with Customer, Liability, Current 9.76M USD
Liabilities, Current 628M USD +2.95%
Deferred Income Tax Liabilities, Net 55.9M USD +7.67%
Operating Lease, Liability, Noncurrent 71.2M USD -9.96%
Other Liabilities, Noncurrent 7.82M USD +5449%
Liabilities 2.84B USD -1.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax 7.36M USD
Retained Earnings (Accumulated Deficit) -2.85B USD +18.1%
Stockholders' Equity Attributable to Parent -207M USD +78.9%
Liabilities and Equity 2.63B USD +37.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 870M USD +1130%
Net Cash Provided by (Used in) Financing Activities 9.41M USD +1643%
Net Cash Provided by (Used in) Investing Activities -184M USD -60.4%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 79.4M shares +3.22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 701M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.03B USD +54.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.16M USD -41.2%
Deferred Tax Assets, Valuation Allowance 858M USD +2.85%
Deferred Tax Assets, Gross 869M USD +3.33%
Operating Lease, Liability 83M USD -10.6%
Payments to Acquire Property, Plant, and Equipment 1.72M USD -82%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 653M USD +60.5%
Lessee, Operating Lease, Liability, to be Paid 122M USD -36.1%
Property, Plant and Equipment, Gross 94.3M USD -31.8%
Operating Lease, Liability, Current 11.7M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14.2M USD -9.22%
Lessee, Operating Lease, Liability, to be Paid, Year One 16.8M USD +3.71%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -12.3%
Deferred Income Tax Expense (Benefit) 2K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.8M USD -60.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.85M USD -41.4%
Unrecognized Tax Benefits 108M USD +7840%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.62M USD -57.5%
Operating Lease, Payments 3.39M USD -14.2%
Additional Paid in Capital 2.63B USD +4.8%
Amortization of Intangible Assets 14.2M USD -92.5%
Depreciation, Depletion and Amortization 7.22M USD -87%
Deferred Tax Assets, Net of Valuation Allowance 11.7M USD +56.9%
Share-based Payment Arrangement, Expense 73.6M USD -9.22%